• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virol Sin . Accelerated Evolution of H7N9 Subtype Influenza Virus under Vaccination Pressure

tetano

Editor, Senior Moderator
Virol Sin


. 2021 May 11.
doi: 10.1007/s12250-021-00383-x. Online ahead of print.
Accelerated Evolution of H7N9 Subtype Influenza Virus under Vaccination Pressure


Yifan Wu[SUP] 1 [/SUP], Jingkai Hu[SUP] 1 [/SUP], Xuanjiang Jin[SUP] 1 [/SUP], Xiao Li[SUP] 1 [/SUP], Jinfeng Wang[SUP] 1 [/SUP], Mengmeng Zhang[SUP] 1 [/SUP], Jianglin Chen[SUP] 1 [/SUP], Shumin Xie[SUP] 2 3 4 [/SUP], Wenbao Qi[SUP] 3 [/SUP], Ming Liao[SUP] 4 [/SUP], Weixin Jia[SUP] 5 6 7 8 9 [/SUP]



Affiliations

Abstract

No avian H7N9 outbreaks have occurred since the introduction of H7N9 inactivated vaccine in the fall of 2017. However, H7N9 is still prevalent in poultry. To surveil the prevalence, genetic characteristics, and antigenic changes of H7N9, over 7000 oropharyngeal and cloaca swab specimens were collected from live poultry markets and farms in 15 provinces of China from 2017 to 2019. A total of 85 influenza virus subtype H7N9 strains were isolated and 20 representative strains were selected for genetic analysis and antigenicity evaluation. Results indicated the decreased prevalence of low-pathogenic H7N9 strains while highly-pathogenic H7N9 strains became dominated since the introduction of vaccine. Phylogenetic analysis showed that strains from 2019 formed an independent small branch and were genetically distant to strains isolated in 2013-2018. Analysis of key amino acid sites showed that the virus strains may adapt to the host environment evolutionally through mutation. Our analysis predicted additional potential glycosylation sites for HA and NA genes in the 2019 strains. Sequence analysis of HA gene in strains isolated from 2018 to 2019 showed that there were an increased nucleotide substitution rate and an increased mutation rate in the first and second nucleotides of coding codons within the open reading frame. The hemagglutination inhibition (HI) assay showed that H7-Re1 and H7-Re2 exhibited a lower HI titer for isolates from 2019, while H7-Re3 and rLN79 showed a high HI titer. The protective effect of the vaccine decreased after 15 months of use. Overall, under vaccination pressure, the evolution of influenza virus subtype H7N9 has accelerated.

Keywords: Epidemiological investigation; Genetic evolution; H7N9; Hemagglutination inhibition assay; Vaccination pressure.
 
Back
Top